Ameriprise’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.7M Buy
2,831,050
+614,298
+28% +$4.42M ﹤0.01% 1374
2026
Q2
$12.8M Buy
+2,216,752
New +$11.2M ﹤0.01% 1871

Other funds holding SOPH

Ameriprise's SOPH Position: Q3 2026 in Review

Ameriprise increased its SOPHiA GENETICS (SOPH) stake by 28% in Q3 2026, buying an estimated $4.42M and bringing the position to 2,831,050 shares worth $23.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Ameriprise first reported a position in SOPH in Q2 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

  • Ameriprise held 2,831,050 shares of SOPHiA GENETICS worth $23.7M as of Q3 2026.
  • Ameriprise bought 614,298 SOPHiA GENETICS shares in Q3 2026, an estimated $4.42M.
  • SOPHiA GENETICS made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #1374 holding.
  • Ameriprise first reported a position in SOPHiA GENETICS in Q2 2026 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.